News

Guided Therapeutics announced it has signed an extension of its distribution agreement with its Russian and Eastern European Sales and Marketing partner, Newmars Group Kft. The…
Read More...

Altasciences is excited to announce the completion of their laboratory expansion. The additional space will be dedicated to ligand binding and cell-based assays. Altasciences’…
Read More...

Glenmark Pharmaceuticals announced the decision to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision is driven by recent findings…
Read More...

Samsung BioLogics, a global leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based in South Korea, announced today that the asset transfer deal…
Read More...

Concept Life Sciences announced the expansion of its regulatory GLP (good laboratory practice) capabilities at the Group’s Dundee and Bradford sites. The MHRA has confirmed the…
Read More...

IRX Therapeutics announced that the company’s assets have been acquired by the newly formed Brooklyn ImmunoTherapeutics LLC. This name reflects the company’s focus on advancing the…
Read More...

AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma,…
Read More...

Quotient Sciences has significantly expanded its formulation development and clinical trial manufacturing operations at its Reading, U.K., facility. The program’s investment has tripled…
Read More...

Bristol-Myers Squibb Company and Infinity Pharmaceuticals announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's Opdivo in combination with Infinity's IPI-549 in…
Read More...

Seattle Genetics announced that it has submitted a supplemental Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) based on data from the phase 3…
Read More...

Lonza and TRACON Pharmaceuticals announced the successful delivery of the first 2,000L single-use bioreactor (SUB) batch produced from the recently expanded Lonza Singapore site. The…
Read More...

MilliporeSigma launched its new BioContinuum Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and…
Read More...

Eli Lilly and Company and NextCure announced a multi-year collaboration focused on the discovery and development of immuno-oncology therapies. The collaboration seeks to discover novel…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LORBRENA® (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase…
Read More...

NuMedii announced the formation of a research collaboration with Johns Hopkins School of Medicine with the goal of discovering new targets and therapeutic options for pancreatitis. The…
Read More...

Denali Therapeutics Inc. announced that it will collaborate with Sanofi on the development of multiple RIPK1 inhibitor molecules with the potential to treat a range of neurological and…
Read More...

Pharmaceutical Product Development, LLC (PPD) has enhanced its global product development services, adding significant expertise in multiple therapeutic areas, including neuroscience,…
Read More...

PMI BioPharma Solutions, a specialty CDMO providing Contract Research, Drug Discovery, Development and Manufacturing Services officially formed in January of 2018, announced that David…
Read More...

Gilead Sciences and Tango Therapeutics announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted immuno-oncology treatments for…
Read More...

Novo Nordisk announced the expansion of its biopharm business with an agreement to acquire the US and Canadian rights to Macrilen(TM) (macimorelin), the first and only FDA-approved oral…
Read More...